Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Belimumab (Benlysta) for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

NCT03207958 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03207958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Belimumab (Benlysta) for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
May 16, 2018
Completion date
February 9, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, graft-versus-host-disease